Class Action Alleges agilon health Hid CEO Termination Before 51.5% Selloff
A class action has been filed on behalf of investors who bought agilon health shares from February 26 to August 4, 2025, alleging the company concealed CEO termination and failed to disclose a Q2 earnings shortfall and suspension of 2025 guidance. The stock plunged 51.5% to $0.88 on August 5.
1. Class Action Lawsuits Initiated by Two Law Firms
Law Offices of Howard G. Smith in Bensalem, Pennsylvania and Law Offices of Frank R. Cruz in Los Angeles have each filed separate securities fraud class action complaints on behalf of investors who purchased agilon health, inc. (“agilon” or the “Company”) securities between February 26, 2025 and August 4, 2025. Both firms allege that agilon investors who suffered losses during this period may file lead plaintiff motions by the March 2, 2026 deadline. The actions seek to recover damages resulting from alleged misrepresentations and omissions concerning the Company’s operations and financial prospects.
2. Triggering Events and Market Reaction
On August 4, 2025, agilon disclosed the departure of its President, CEO and board director, characterizing the exit as a termination without cause under his employment agreement. Concurrently, the Company reported second quarter 2025 results that missed analyst expectations and announced suspension of its full-year guidance, citing leadership transition, ongoing initiative execution and market uncertainty. In response, the share price plunged by over 50% the following trading day, inflicting significant losses on shareholders.
3. Allegations of Misleading Statements
The complaints allege that throughout the Class Period agilon’s executives issued overly optimistic guidance and positive statements without a reasonable basis, while failing to disclose material adverse facts. Specifically, plaintiffs claim that defendants knew or should have known that 2025 guidance was unattainable given industry headwinds, that the financial impact from strategic risk-reduction actions was overstated, and that public statements about the Company’s prospects were materially misleading.
4. Next Steps for Investors
Investors who purchased agilon securities during the Class Period and suffered losses are invited to contact either law firm for information on participating in the actions or filing lead plaintiff motions. The Law Offices of Howard G. Smith can be reached at howardsmith@howardsmithlaw.com or (215) 638-4847, and the Law Offices of Frank R. Cruz at info@frankcruzlaw.com or (310) 914-5007. Interested parties have until March 2, 2026 to take action.